암페놀엠씨피코리아

비상장계속사업자

Amphenol MCP Korea Ltd

스티븐비더로우

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

암페놀엠씨피코리아

Business Reg. No. 1238140508 · CEO 스티븐비더로우

I.Investment Overview

Target암페놀엠씨피코리아 (1238140508)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명암페놀엠씨피코리아
영문명Amphenol MCP Korea Ltd
대표자스티븐비더로우
사업자등록번호1238140508
법인등록번호1348140000971
설립일1993.08.17

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW102.2202165202270.9202347.4202445.42025
영업이익100M KRW5.32021-2.22022-0.22023-12024-0.42025
순이익100M KRW609.42021538.62022813.32023743.42024396.82025
Item20252024202320222021
자산총계1,815.2억원1,380.4억원1,806.4억원2,176.2억원1,839.6억원
부채총계14.7억원11.7억원21.6억원305.2억원216.7억원
자본총계1,800.5억원1,368.7억원1,784.8억원1,871억원1,622.9억원
매출액45.4억원47.4억원70.9억원65억원102.2억원
영업이익-4,464만원-1억원-1,814만원-2.2억원5.3억원
순이익396.8억원743.4억원813.3억원538.6억원609.4억원

VI.Financial Ratios

FY2025 basis

-0.98%

영업이익률

873.4%

순이익률

21.86%

ROA

22.04%

ROE

0.82%

부채비율

99.19%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

암페놀엠씨피코리아 투심보고서 | Alpha Lenz